Literature DB >> 12759421

TCR signal transduction in antigen-specific memory CD8 T cells.

Ellen N Kersh1, Susan M Kaech, Thandi M Onami, Miriana Moran, E John Wherry, M Carrie Miceli, Rafi Ahmed.   

Abstract

Memory T cells are more responsive to Ag than naive cells. To determine whether memory T cells also have more efficient TCR signaling, we compared naive, effector, and memory CD8 T cells of the same antigenic specificity. Surprisingly, initial CD3 signaling events are indistinguishable. However, memory T cells have more extensive lipid rafts with higher phosphoprotein content before TCR engagement. Upon activation in vivo, they more efficiently induce phosphorylation of-LAT (linker for activation of T cells), ERK (extracellular signal-regulated kinase), JNK (c-Jun N-terminal kinase), and p38. Thus, memory CD8 T cells do not increase their TCR sensitivity, but are better poised to augment downstream signals. We propose that this regulatory mechanism might increase signal transduction in memory T cells, while limiting TCR cross-reactivity and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759421     DOI: 10.4049/jimmunol.170.11.5455

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection.

Authors:  Miles P Davenport; Ruy M Ribeiro; Alan S Perelson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 2.  TCR signaling requirements for activating T cells and for generating memory.

Authors:  Dietmar Zehn; Carolyn King; Michael J Bevan; Ed Palmer
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

3.  CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Authors:  Dmitry M Gakamsky; Immanuel F Luescher; Aladdin Pramanik; Ronen B Kopito; François Lemonnier; Horst Vogel; Rudolf Rigler; Israel Pecht
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

4.  CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability.

Authors:  Gerritje J W van der Windt; David O'Sullivan; Bart Everts; Stanley Ching-Cheng Huang; Michael D Buck; Jonathan D Curtis; Chih-Hao Chang; Amber M Smith; Teresa Ai; Brandon Faubert; Russell G Jones; Edward J Pearce; Erika L Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

5.  Histone acetyltransferase CBP is critical for conventional effector and memory T-cell differentiation in mice.

Authors:  Ann R Piccirillo; Richard T Cattley; Louise M D'Cruz; William F Hawse
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

6.  MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner.

Authors:  Takero Shindo; Tae Kon Kim; Cara L Benjamin; Eric D Wieder; Robert B Levy; Krishna V Komanduri
Journal:  Blood       Date:  2013-04-10       Impact factor: 22.113

7.  Reproducible selection of high avidity CD8+ T-cell clones following secondary acute virus infection.

Authors:  Tania Cukalac; Jesseka Chadderton; Andreas Handel; Peter C Doherty; Stephen J Turner; Paul G Thomas; Nicole L La Gruta
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 8.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

Review 9.  Biochemical signaling pathways for memory T cell recall.

Authors:  Donna L Farber
Journal:  Semin Immunol       Date:  2009-04       Impact factor: 11.130

10.  The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

Authors:  Pankaj Tailor; Sue Tsai; Afshin Shameli; Pau Serra; Jinguo Wang; Stephen Robbins; Masao Nagata; Andrea L Szymczak-Workman; Dario A A Vignali; Pere Santamaria
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.